Emerging drugs for the treatment of metastatic renal cancer

Author： Samlowski Wolfram E   Vogelzang Nicholas J  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.4, 2007-11, pp. : 605-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs in metastatic breast cancer: an update

By Arslan Cagatay   Altundag Kadri   Dizdar Omer  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 647-667

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the treatment of pancreatic cancer

By Van Laethem Jean-Luc   Marechal Raphael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 301-311

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of pancreatic cancer

By Mahalingam Devalingam   Kelly Kevin R   Swords Ronan T   Carew Jennifer   Nawrocki Steffan T   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 311-328

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of advanced gastric cancer

By Tetzlaff Eric D   Cen Putao   Ajani Jaffer A  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for renal failure

By Chatterjee Prabal K   Thiemermann Christoph  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 389-435

Informa Healthcare

Access to resources Recommend Favorite